Nordic Life Science Pipeline Inc.   Report issue

For profit Phase 2
Founded: Quebec Canada (2009)
Status: Left NME R&D (2018)

Organization Overview

First Clinical Trial
2013
NCT01484184
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now